$TXG Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in 10x Genomics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in 10x Genomics, Inc.. Get notifications about new insider transactions in 10x Genomics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 15 2021 | TXG | 10x Genomics, Inc. | ROBERTS BRYAN E | Director | Option Exercise | A | 193.51 | 1,563 | 302,456 | 1,563 | |
Jun 15 2021 | TXG | 10x Genomics, Inc. | ROBERTS BRYAN E | Director | Grant | A | 0.00 | 625 | 0 | 625 | 0 to 625 |
May 26 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Option Exercise | A | 177.76 | 22,338 | 3,970,803 | 22,338 | |
May 26 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 162.66 | 281 | 45,707 | 39,011 | 39.3 K to 39 K (-0.72 %) |
May 26 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Grant | A | 0.00 | 8,935 | 0 | 39,292 | 30.4 K to 39.3 K (+29.43 %) |
May 13 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | M | 1.16 | 17,000 | 19,720 | 545,000 | |
May 13 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 137.57 | 100 | 13,757 | 34,608 | 34.7 K to 34.6 K (-0.29 %) |
May 13 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 136.80 | 1,200 | 164,164 | 34,708 | 35.9 K to 34.7 K (-3.34 %) |
May 13 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 135.74 | 2,702 | 366,781 | 35,908 | 38.6 K to 35.9 K (-7.00 %) |
May 13 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 134.70 | 7,875 | 1,060,759 | 38,610 | 46.5 K to 38.6 K (-16.94 %) |
May 13 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 133.86 | 5,123 | 685,759 | 46,485 | 51.6 K to 46.5 K (-9.93 %) |
May 13 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Buy | M | 1.16 | 17,000 | 19,720 | 51,608 | 34.6 K to 51.6 K (+49.12 %) |
May 05 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Option Exercise | M | 11.48 | 9,792 | 112,412 | 97,296 | |
May 05 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Option Exercise | M | 5.04 | 5,208 | 26,248 | 89,782 | |
May 05 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 188.75 | 200 | 37,749 | 880,468 | 880.7 K to 880.5 K (-0.02 %) |
May 05 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 186.75 | 100 | 18,675 | 880,668 | 880.8 K to 880.7 K (-0.01 %) |
May 05 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 185.91 | 1,100 | 204,505 | 880,768 | 881.9 K to 880.8 K (-0.12 %) |
May 05 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 185.04 | 2,951 | 546,042 | 881,868 | 884.8 K to 881.9 K (-0.33 %) |
May 05 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 184.20 | 6,644 | 1,223,855 | 884,819 | 891.5 K to 884.8 K (-0.75 %) |
May 05 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 183.06 | 2,100 | 384,418 | 891,463 | 893.6 K to 891.5 K (-0.24 %) |
May 05 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 182.14 | 1,200 | 218,570 | 893,563 | 894.8 K to 893.6 K (-0.13 %) |
May 05 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 180.94 | 505 | 91,372 | 894,763 | 895.3 K to 894.8 K (-0.06 %) |
May 05 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 179.71 | 200 | 35,941 | 895,268 | 895.5 K to 895.3 K (-0.02 %) |
May 05 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Buy | M | 11.48 | 9,792 | 112,412 | 895,468 | 885.7 K to 895.5 K (+1.11 %) |
May 05 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Buy | M | 5.04 | 5,208 | 26,248 | 885,676 | 880.5 K to 885.7 K (+0.59 %) |
May 05 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 198.09 | 100 | 19,809 | 420,991 | 421.1 K to 421 K (-0.02 %) |
May 05 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 194.90 | 100 | 19,490 | 421,091 | 421.2 K to 421.1 K (-0.02 %) |
May 05 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 193.84 | 300 | 58,152 | 421,191 | 421.5 K to 421.2 K (-0.07 %) |
May 05 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 192.54 | 2,200 | 423,583 | 421,491 | 423.7 K to 421.5 K (-0.52 %) |
May 05 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 191.83 | 2,880 | 552,462 | 423,691 | 426.6 K to 423.7 K (-0.68 %) |
May 05 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 190.53 | 1,320 | 251,504 | 426,571 | 427.9 K to 426.6 K (-0.31 %) |
May 05 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 189.25 | 600 | 113,551 | 427,891 | 428.5 K to 427.9 K (-0.14 %) |
May 05 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Option Exercise | M | 5.04 | 10,000 | 50,400 | 430,159 | |
May 05 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 198.09 | 100 | 19,809 | 30,357 | 30.5 K to 30.4 K (-0.33 %) |
May 05 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 194.92 | 200 | 38,984 | 30,457 | 30.7 K to 30.5 K (-0.65 %) |
May 05 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 193.40 | 794 | 153,560 | 30,657 | 31.5 K to 30.7 K (-2.52 %) |
May 05 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 192.46 | 3,706 | 713,241 | 31,451 | 35.2 K to 31.5 K (-10.54 %) |
May 05 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 191.77 | 2,700 | 517,783 | 35,157 | 37.9 K to 35.2 K (-7.13 %) |
May 05 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 190.63 | 1,900 | 362,191 | 37,857 | 39.8 K to 37.9 K (-4.78 %) |
May 05 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 189.57 | 600 | 113,743 | 39,757 | 40.4 K to 39.8 K (-1.49 %) |
May 05 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Buy | M | 5.04 | 10,000 | 50,400 | 40,357 | 30.4 K to 40.4 K (+32.94 %) |
May 05 2021 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Option Exercise | M | 1.20 | 17,586 | 21,103 | 154,414 | |
May 05 2021 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Option Exercise | M | 1.07 | 24,080 | 25,766 | 53,952 | |
May 05 2021 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 197.91 | 600 | 118,746 | 36,636 | 37.2 K to 36.6 K (-1.61 %) |
May 05 2021 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 194.88 | 500 | 97,439 | 37,236 | 37.7 K to 37.2 K (-1.32 %) |
May 05 2021 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 193.97 | 800 | 155,174 | 37,736 | 38.5 K to 37.7 K (-2.08 %) |
May 05 2021 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 192.96 | 5,361 | 1,034,433 | 38,536 | 43.9 K to 38.5 K (-12.21 %) |
May 05 2021 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 192.10 | 20,100 | 3,861,274 | 43,897 | 64 K to 43.9 K (-31.41 %) |
May 05 2021 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 191.07 | 7,905 | 1,510,393 | 63,997 | 71.9 K to 64 K (-10.99 %) |
May 05 2021 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 190.19 | 4,908 | 933,450 | 71,902 | 76.8 K to 71.9 K (-6.39 %) |
May 05 2021 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 189.07 | 1,492 | 282,097 | 76,810 | 78.3 K to 76.8 K (-1.91 %) |
May 05 2021 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Buy | M | 1.20 | 17,586 | 21,103 | 78,302 | 60.7 K to 78.3 K (+28.96 %) |
May 05 2021 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Buy | M | 1.07 | 24,080 | 25,766 | 60,716 | 36.6 K to 60.7 K (+65.73 %) |
Apr 27 2021 | TXG | 10x Genomics, Inc. | Kosaraju Sridhar | Director | Sell | S | 194.74 | 100 | 19,474 | 15,000 | 15.1 K to 15 K (-0.66 %) |
Apr 27 2021 | TXG | 10x Genomics, Inc. | Kosaraju Sridhar | Director | Sell | S | 193.98 | 600 | 116,386 | 15,100 | 15.7 K to 15.1 K (-3.82 %) |
Apr 27 2021 | TXG | 10x Genomics, Inc. | Kosaraju Sridhar | Director | Sell | S | 193.11 | 400 | 77,246 | 15,700 | 16.1 K to 15.7 K (-2.48 %) |
Apr 27 2021 | TXG | 10x Genomics, Inc. | Kosaraju Sridhar | Director | Sell | S | 191.71 | 300 | 57,513 | 16,100 | 16.4 K to 16.1 K (-1.83 %) |
Apr 27 2021 | TXG | 10x Genomics, Inc. | Kosaraju Sridhar | Director | Sell | S | 190.05 | 100 | 19,005 | 16,400 | 16.5 K to 16.4 K (-0.61 %) |
Apr 19 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 195.74 | 300 | 58,723 | 428,491 | 428.8 K to 428.5 K (-0.07 %) |
Apr 19 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 194.83 | 1,393 | 271,394 | 428,791 | 430.2 K to 428.8 K (-0.32 %) |
Apr 19 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 193.86 | 1,600 | 310,172 | 430,184 | 431.8 K to 430.2 K (-0.37 %) |
Apr 19 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 192.85 | 926 | 178,578 | 431,784 | 432.7 K to 431.8 K (-0.21 %) |
Apr 19 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 191.85 | 681 | 130,650 | 432,710 | 433.4 K to 432.7 K (-0.16 %) |
Apr 19 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 190.70 | 1,500 | 286,056 | 433,391 | 434.9 K to 433.4 K (-0.34 %) |
Apr 19 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 189.97 | 1,100 | 208,971 | 434,891 | 436 K to 434.9 K (-0.25 %) |
Apr 13 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | M | 1.16 | 17,000 | 19,720 | 562,000 | |
Apr 13 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 192.17 | 300 | 57,652 | 34,608 | 34.9 K to 34.6 K (-0.86 %) |
Apr 13 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 190.31 | 1,100 | 209,340 | 34,908 | 36 K to 34.9 K (-3.05 %) |
Apr 13 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 189.34 | 1,400 | 265,075 | 36,008 | 37.4 K to 36 K (-3.74 %) |
Apr 13 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 188.36 | 2,398 | 451,695 | 37,408 | 39.8 K to 37.4 K (-6.02 %) |
Apr 13 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 187.10 | 1,996 | 373,450 | 39,806 | 41.8 K to 39.8 K (-4.77 %) |
Apr 13 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 186.31 | 2,855 | 531,911 | 41,802 | 44.7 K to 41.8 K (-6.39 %) |
Apr 13 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 185.14 | 1,500 | 277,714 | 44,657 | 46.2 K to 44.7 K (-3.25 %) |
Apr 13 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 184.32 | 600 | 110,591 | 46,157 | 46.8 K to 46.2 K (-1.28 %) |
Apr 13 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 182.75 | 1,302 | 237,938 | 46,757 | 48.1 K to 46.8 K (-2.71 %) |
Apr 13 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 181.84 | 2,642 | 480,426 | 48,059 | 50.7 K to 48.1 K (-5.21 %) |
Apr 13 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 181.10 | 907 | 164,260 | 50,701 | 51.6 K to 50.7 K (-1.76 %) |
Apr 13 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Buy | M | 1.16 | 17,000 | 19,720 | 51,608 | 34.6 K to 51.6 K (+49.12 %) |
Apr 08 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Option Exercise | M | 11.48 | 9,792 | 112,412 | 107,088 | |
Apr 08 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Option Exercise | M | 5.04 | 5,208 | 26,248 | 94,990 | |
Apr 08 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 199.41 | 100 | 19,941 | 880,468 | 880.6 K to 880.5 K (-0.01 %) |
Apr 08 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 198.69 | 800 | 158,953 | 880,568 | 881.4 K to 880.6 K (-0.09 %) |
Apr 08 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 197.48 | 2,849 | 562,605 | 881,368 | 884.2 K to 881.4 K (-0.32 %) |
Apr 08 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 196.61 | 5,428 | 1,067,222 | 884,217 | 889.6 K to 884.2 K (-0.61 %) |
Apr 08 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 195.81 | 1,097 | 214,807 | 889,645 | 890.7 K to 889.6 K (-0.12 %) |
Apr 08 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 194.44 | 1,826 | 355,052 | 890,742 | 892.6 K to 890.7 K (-0.20 %) |
Apr 08 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 193.48 | 1,900 | 367,604 | 892,568 | 894.5 K to 892.6 K (-0.21 %) |
Apr 08 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 192.47 | 200 | 38,493 | 894,468 | 894.7 K to 894.5 K (-0.02 %) |
Apr 08 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 190.58 | 800 | 152,465 | 894,668 | 895.5 K to 894.7 K (-0.09 %) |
Apr 08 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Buy | M | 11.48 | 9,792 | 112,412 | 895,468 | 885.7 K to 895.5 K (+1.11 %) |
Apr 08 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Buy | M | 5.04 | 5,208 | 26,248 | 885,676 | 880.5 K to 885.7 K (+0.59 %) |
Apr 02 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 185.90 | 600 | 111,542 | 435,991 | 436.6 K to 436 K (-0.14 %) |
Apr 02 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 185.22 | 3,487 | 645,844 | 436,591 | 440.1 K to 436.6 K (-0.79 %) |
Apr 02 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 184.22 | 2,272 | 418,539 | 440,078 | 442.4 K to 440.1 K (-0.51 %) |
Apr 02 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 183.19 | 700 | 128,233 | 442,350 | 443.1 K to 442.4 K (-0.16 %) |
Apr 02 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 181.83 | 200 | 36,365 | 443,050 | 443.3 K to 443.1 K (-0.05 %) |
Apr 02 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 180.28 | 241 | 43,446 | 443,250 | 443.5 K to 443.3 K (-0.05 %) |
Apr 02 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Option Exercise | M | 5.04 | 10,000 | 50,400 | 440,159 | |
Apr 02 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 185.76 | 1,800 | 334,361 | 30,357 | 32.2 K to 30.4 K (-5.60 %) |
Apr 02 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 185.02 | 3,795 | 702,152 | 32,157 | 36 K to 32.2 K (-10.56 %) |
Apr 02 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 184.12 | 3,205 | 590,096 | 35,952 | 39.2 K to 36 K (-8.18 %) |
Apr 02 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 183.19 | 700 | 128,231 | 39,157 | 39.9 K to 39.2 K (-1.76 %) |
Apr 02 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 181.83 | 200 | 36,365 | 39,857 | 40.1 K to 39.9 K (-0.50 %) |
Apr 02 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 180.02 | 300 | 54,007 | 40,057 | 40.4 K to 40.1 K (-0.74 %) |
Apr 02 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Buy | M | 5.04 | 10,000 | 50,400 | 40,357 | 30.4 K to 40.4 K (+32.94 %) |
Mar 25 2021 | TXG | 10x Genomics, Inc. | Kosaraju Sridhar | Director | Sell | S | 178.07 | 200 | 35,613 | 16,500 | 16.7 K to 16.5 K (-1.20 %) |
Mar 25 2021 | TXG | 10x Genomics, Inc. | Kosaraju Sridhar | Director | Sell | S | 175.71 | 100 | 17,571 | 16,700 | 16.8 K to 16.7 K (-0.60 %) |
Mar 25 2021 | TXG | 10x Genomics, Inc. | Kosaraju Sridhar | Director | Sell | S | 173.96 | 1,200 | 208,755 | 16,800 | 18 K to 16.8 K (-6.67 %) |
Mar 25 2021 | TXG | 10x Genomics, Inc. | Kosaraju Sridhar | Director | Gift | G | 0.00 | 7,167 | 0 | 18,000 | 10.8 K to 18 K (+66.16 %) |
Mar 25 2021 | TXG | 10x Genomics, Inc. | Kosaraju Sridhar | Director | Gift | G | 0.00 | 7,167 | 0 | 2,833 | 10 K to 2.8 K (-71.67 %) |
Mar 18 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 174.50 | 400 | 69,798 | 443,491 | 443.9 K to 443.5 K (-0.09 %) |
Mar 18 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 173.28 | 400 | 69,313 | 443,891 | 444.3 K to 443.9 K (-0.09 %) |
Mar 18 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 172.29 | 1,266 | 218,114 | 444,291 | 445.6 K to 444.3 K (-0.28 %) |
Mar 18 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 171.27 | 500 | 85,637 | 445,557 | 446.1 K to 445.6 K (-0.11 %) |
Mar 18 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 170.09 | 813 | 138,281 | 446,057 | 446.9 K to 446.1 K (-0.18 %) |
Mar 18 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 169.27 | 1,100 | 186,199 | 446,870 | 448 K to 446.9 K (-0.25 %) |
Mar 18 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 167.98 | 920 | 154,540 | 447,970 | 448.9 K to 448 K (-0.20 %) |
Mar 18 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 166.80 | 601 | 100,247 | 448,890 | 449.5 K to 448.9 K (-0.13 %) |
Mar 18 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 165.80 | 800 | 132,637 | 449,491 | 450.3 K to 449.5 K (-0.18 %) |
Mar 18 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 164.88 | 700 | 115,416 | 450,291 | 451 K to 450.3 K (-0.16 %) |
Mar 16 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Option Exercise | M | 11.48 | 9,791 | 112,401 | 116,880 | |
Mar 16 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Option Exercise | M | 5.04 | 5,209 | 26,253 | 100,198 | |
Mar 16 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 159.35 | 3,174 | 505,768 | 880,468 | 883.6 K to 880.5 K (-0.36 %) |
Mar 16 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 158.49 | 1,933 | 306,355 | 883,642 | 885.6 K to 883.6 K (-0.22 %) |
Mar 16 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 157.42 | 2,384 | 375,285 | 885,575 | 888 K to 885.6 K (-0.27 %) |
Mar 16 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 156.35 | 3,105 | 485,463 | 887,959 | 891.1 K to 888 K (-0.35 %) |
Mar 16 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 155.35 | 2,904 | 451,147 | 891,064 | 894 K to 891.1 K (-0.32 %) |
Mar 16 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 154.37 | 1,500 | 231,551 | 893,968 | 895.5 K to 894 K (-0.17 %) |
Mar 16 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Option Exercise | M | 11.48 | 9,791 | 112,401 | 116,880 | |
Mar 16 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Buy | M | 11.48 | 9,791 | 112,401 | 895,468 | 885.7 K to 895.5 K (+1.11 %) |
Mar 16 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Option Exercise | M | 5.04 | 5,209 | 26,253 | 100,198 | |
Mar 16 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Buy | M | 5.04 | 5,209 | 26,253 | 885,677 | 880.5 K to 885.7 K (+0.59 %) |
Mar 16 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 159.35 | 3,174 | 505,768 | 880,468 | 883.6 K to 880.5 K (-0.36 %) |
Mar 16 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 158.49 | 1,933 | 306,355 | 883,642 | 885.6 K to 883.6 K (-0.22 %) |
Mar 16 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 157.42 | 2,384 | 375,285 | 885,575 | 888 K to 885.6 K (-0.27 %) |
Mar 16 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 156.35 | 3,105 | 485,463 | 887,959 | 891.1 K to 888 K (-0.35 %) |
Mar 16 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 155.35 | 2,904 | 451,147 | 891,064 | 894 K to 891.1 K (-0.32 %) |
Mar 16 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 154.37 | 1,500 | 231,551 | 893,968 | 895.5 K to 894 K (-0.17 %) |
Mar 16 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Buy | M | 11.48 | 9,791 | 112,401 | 895,468 | 885.7 K to 895.5 K (+1.11 %) |
Mar 16 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Buy | M | 5.04 | 5,209 | 26,253 | 885,677 | 880.5 K to 885.7 K (+0.59 %) |
Mar 16 2021 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Option Exercise | M | 1.07 | 5,302 | 5,673 | 119,698 | |
Mar 16 2021 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Option Exercise | M | 0.88 | 36,364 | 32,000 | 0 | |
Mar 16 2021 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 159.40 | 7,167 | 1,142,386 | 36,636 | 43.8 K to 36.6 K (-16.36 %) |
Mar 16 2021 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 158.64 | 6,368 | 1,010,223 | 43,803 | 50.2 K to 43.8 K (-12.69 %) |
Mar 16 2021 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 157.48 | 5,845 | 920,452 | 50,171 | 56 K to 50.2 K (-10.43 %) |
Mar 16 2021 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 156.45 | 8,189 | 1,281,143 | 56,016 | 64.2 K to 56 K (-12.75 %) |
Mar 16 2021 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 155.54 | 8,074 | 1,255,815 | 64,205 | 72.3 K to 64.2 K (-11.17 %) |
Mar 16 2021 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 154.56 | 6,023 | 930,887 | 72,279 | 78.3 K to 72.3 K (-7.69 %) |
Mar 16 2021 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Buy | M | 1.07 | 5,302 | 5,673 | 78,302 | 73 K to 78.3 K (+7.26 %) |
Mar 16 2021 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Option Exercise | M | 1.07 | 5,302 | 5,673 | 119,698 |